
Sign up to save your podcasts
Or
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
4.1
9090 ratings
In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 2024 and beyond.
491 Listeners
194 Listeners
93 Listeners
2,190 Listeners
982 Listeners
290 Listeners
250 Listeners
175 Listeners
58 Listeners
1,267 Listeners
77 Listeners
22 Listeners
25 Listeners
21 Listeners
71 Listeners